ClinicalTrials.Veeva

Menu

Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System

M

Methodist Health System

Status

Enrolling

Conditions

Invasive Lobular Breast Carcinoma
Ductal Carcinoma in Situ

Treatments

Procedure: managing Male Breast Cancer Patients at Methodist Health System

Study type

Observational

Funder types

Other

Identifiers

NCT06133647
015.MTP.2023.A

Details and patient eligibility

About

To determine the number of MBC cases as well as the demographics, characteristics, and outcomes of MBC patients at Methodist Health System (MHS).

Full description

Male breast cancer (MBC) is a rare disease without sufficient clinical data supporting the management and treatment. The treatment of MBC arises from data extrapolated from female breast cancer (FBC). MBC has higher mortality than FBC. Previous studies have suggested differences between MBC and FBC; however, treatments remain the same for both. Larger studies in MBC are needed to provide more clinical data to help guide treatment.

Enrollment

8 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • • ≥ 18 years of age Patients diagnosed with ductal carcinoma in situ or invasive lobular carcinoma of the breast

Exclusion criteria

  • 18 years of age

    • Prisoners
    • Pregnant or breastfeeding

Trial contacts and locations

1

Loading...

Central trial contact

Colette N Ngo Ndjom, MS; Kasim W Bhimani, BA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems